rhein has been researched along with Non-alcoholic Fatty Liver Disease in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 2 (66.67) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, W; Li, S; Ma, Y; Wu, X; Zhang, H | 1 |
| Chen, W; Li, S; Ma, Y | 1 |
| Bian, DX; Chen, JY; Guo, JC; Liu, H; Liu, J; Liu, YL; Lu, L; Luo, Y; Shi, JP; Xun, YH; Yang, WJ; Zhuang, ZJ | 1 |
3 other study(ies) available for rhein and Non-alcoholic Fatty Liver Disease
| Article | Year |
|---|---|
Prediction and verification of the active ingredients and potential targets of Erhuang Quzhi Granules on non-alcoholic fatty liver disease based on network pharmacology.
Topics: Animals; Drugs, Chinese Herbal; Emodin; Lipids; Mice; Molecular Docking Simulation; Network Pharmacology; NF-kappa B; Non-alcoholic Fatty Liver Disease; Tumor Necrosis Factor-alpha | 2023 |
Active ingredients of Erhuang Quzhi Granules for treating non-alcoholic fatty liver disease based on the NF-κB/NLRP3 pathway.
Topics: Animals; Curcumin; Emodin; Inflammasomes; Molecular Docking Simulation; Molecular Structure; NF-kappa B; NLR Family, Pyrin Domain-Containing 3 Protein; Non-alcoholic Fatty Liver Disease | 2023 |
[Protective effects of rhein on hepatic progression in HBV-transgenic mice with nonalcoholic steatohepatitis induced by a high-fat diet].
Topics: Animals; Anthraquinones; Diet, High-Fat; Disease Models, Animal; Disease Progression; Fatty Liver; Female; Glucose; Hepatitis B virus; Hepatitis B, Chronic; Humans; Lipid Metabolism; Male; Mice; Mice, Inbred BALB C; Mice, Transgenic; Non-alcoholic Fatty Liver Disease | 2013 |